A systematic review and meta-analysis on the effect of angiogenesis blockade for the treatment of gastric cancer

A systematic review and meta-analysis on the effect of angiogenesis blockade for the treatment of gastric cancer

Zhi-Gang Bai, Zhong-Tao Zhang Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Cancer Invasion and Metastasis Research and National Clinical Research Center for Digestive Diseases, Beijing 100050, People’s Republic of China...

Full description

Bibliographic Details
Main Authors:	Bai ZG, Zhang ZT
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-10-01
Series:	OncoTargets and Therapy
Subjects:	anti-VEGF monoclonal antibody anti-VEGF receptor mAb VEGFR tyrosine kinase inhibitors phase III trial overall survival progress free survival chemotherapy
Online Access:	https://www.dovepress.com/a-systematic-review-and-meta-analysis-on-the-effect-of-angiogenesis-bl-peer-reviewed-article-OTT

Similar Items

Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy
by: Shuang Qin, et al.
Published: (2019-03-01)

Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis
by: Megan Stevens, et al.
Published: (2019-03-01)

Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
by: Chen Gang, et al.
Published: (2012-03-01)

Old Player-New Tricks: Non Angiogenic Effects of the VEGF/VEGFR Pathway in Cancer
by: Panagiotis Ntellas, et al.
Published: (2020-10-01)

Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies
by: Karam Khaddour, et al.
Published: (2021-06-01)

Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases
by: Asghar Fallah, et al.
Published: (2019-02-01)

Generation of Anti-HIV-1 envelope monoclonal antibodies using B-cells from HIV-1 sub-type C infected individuals with high levels of neutralizing antibodies
by: Nhlapo, Jabulani
Published: (2006)

Influence d’inhibiteurs tyrosine kinase sur la biologie et la survie de cellules de cancer colorectal
by: Mésange, Paul
Published: (2014)

Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis
by: Jing Yu, et al.
Published: (2016-10-01)

Multifaceted Role of the Placental Growth Factor (PlGF) in the Antitumor Immune Response and Cancer Progression
by: Loredana Albonici, et al.
Published: (2019-06-01)

Is the effect of melatonin on vascular endothelial growth factor receptor-2 associated with angiogenesis in the rat ovary?
by: Yasemin Behram Kandemir, et al.
Published: (2019-03-01)

Monoclonal Antibody Therapies against Anthrax
by: Zhaochun Chen, et al.
Published: (2011-08-01)

Systemic treatment in advanced soft tissue sarcoma: what is standard, what is new
by: Anna Maria Frezza, et al.
Published: (2017-06-01)

A Cyclic Peptide Epitope of an Under-Explored VEGF-B Loop 1 Demonstrated In Vivo Anti-Angiogenic and Anti-Tumor Activities
by: Lei Wang, et al.
Published: (2021-09-01)

CLINICAL ANALYSIS OF SERUM INTERLEUKIN-16 AND VASCULAR ENDOTHELIAL GROWTH FACTOR LEVELS DEPENDING ON MORPHOLOGICAL CHARACTERISTICS OF THE TUMORS AND LONG-TERM TREATMENT OUTCOMES IN PATIENTS WITH BONE NEOPLASMS
by: I. V. Babkina, et al.
Published: (2017-01-01)

ARE THE HIGH SERUM INTERLEUKIN-6 AND VASCULAR ENDOTHELIAL GROWTH FACTOR LEVELS AN USEFUL PROGNOSTIC MARKERS IN AGGRESSIVE NON-HODGKIN'S LYMPHOMA PATIENTS?
by: Hava Üsküdar Teke
Published: (2014-08-01)

Coadjuvant Anti-VEGF A Therapy Improves Survival in Patients with Colorectal Cancer with Liver Metastasis: A Systematic Review
by: Isabel Novo, et al.
Published: (2020-04-01)

Assessment of a New Nanostructured Microemulsion System for Ocular Delivery of Sorafenib to Posterior Segment of the Eye
by: Manuela Santonocito, et al.
Published: (2021-04-01)

Immunohistochemical expression of VEGF in relation to VEGFR and CD34 in NHL using digital image analysis system
by: Bassam Mohammad Hameed, et al.
Published: (2016-01-01)

Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases
by: Flego Michela, et al.
Published: (2013-01-01)

Pyrazoles as potential anti-angiogenesis agents: A contemporary overview
by: Konstantinos M Kasiotis, et al.
Published: (2014-09-01)

Etude de l’efficacité des stratégies d’immunothérapies actives anti-cytokine et évaluation des conséquences de la vaccination anti-TNF dans des modèles infectieux
by: Belmellat-Bouadi, Nadia
Published: (2016)

Etiology and management of hypertension in patients with cancer
by: Turab Mohammed, et al.
Published: (2021-04-01)

Angiogenesis‐related gene expression profile in clinical cases of canine cancer
by: Atsushi Tanabe, et al.
Published: (2019-02-01)

Rola czynnika wzrostu śródbłonka naczyniowego w patogenezie łuszczycy
by: Bożena Chodynicka, et al.
Published: (2011-01-01)

Association study between the polymorphisms of angiogenesis‐related genes and cervical cancer susceptibility in Chinese Uygur population
by: Lili Han, et al.
Published: (2019-10-01)

Elevated serum levels of vascular endothelial growth factor predict a poor prognosis of platinum-based chemotherapy in non-small cell lung cancer
by: Zang JL, et al.
Published: (2017-01-01)

Overview of Current Targeted Anti-Cancer Drugs for Therapy in Onco-Hematology
by: Stefania Crisci, et al.
Published: (2019-07-01)

Overview of Targeted Drugs for Mature B-Cell Non-hodgkin Lymphomas
by: Stefania Crisci, et al.
Published: (2019-06-01)

Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
by: Ming Yi, et al.
Published: (2019-03-01)

Continuous epidermal growth factor receptor-tyrosine kinase inhibitor administration in primary lung adenocarcinoma patients harboring favorable mutations with controlled target lung tumors dose not hinder survival benefit despite small new lesions
by: Ping-Chih Hsu, et al.
Published: (2016-04-01)

The Yin and Yang of VEGF and PEDF: Multifaceted Neurotrophic Factors and Their Potential in the Treatment of Parkinson’s Disease
by: Scott J. Sherman, et al.
Published: (2010-08-01)

Acquired Hypothyroidism in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors
by: Wu J, et al.
Published: (2020-09-01)

Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer
by: Hung‐Chih Hsu, et al.
Published: (2019-07-01)

Novel targeted agents for gastric cancer
by: Liu Lian, et al.
Published: (2012-06-01)

Monoclonal antibodies in pediatric allergy
by: Amelia Licari, et al.
Published: (2015-10-01)

Angiogenesis Inhibitors for Colorectal Cancer. A Review of the Clinical Data
by: Torben Frøstrup Hansen, et al.
Published: (2021-03-01)

Expressão do fator de crescimento endotelial vascular (VEGF) e seus receptores VEGFR-1 e VEGFR-2 durante o início da gestação em camundongos.
by: Luciana Oliveira da Silva
Published: (2008)

Expressão do fator de crescimento endotelial vascular (VEGF) e seus receptores VEGFR-1 e VEGFR-2 durante o início da gestação em camundongos.
by: Silva, Luciana Oliveira da
Published: (2008)

Molecular Therapeutic Approaches for Pediatric Acute Myeloid Leukemia
by: Sarah K Tasian, et al.
Published: (2014-03-01)

Cannot write session to /tmp/vufind_sessions/sess_umc767c2hm1qds1otdol3fmaks